Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 1947-1950, September 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mallinger, A. G.
Right arrow Articles by Carter, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mallinger, A. G.
Right arrow Articles by Carter, J. C.

Preparation of Boron-containing Bovine {gamma}-Globulin as a Model Compound for a New Approach to Slow Neutron Therapy of Tumors1

Alan G. Mallinger2, Edward L. Jozwiak, Jr. and James C. Carter3

Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15213

The N-carboxy anhydride of DL-4-boronophenylalanine was synthesized and used to prepare soluble copoly (DL-alanyl-DL-4-boronophenylalanyl) bovine {gamma}-globulin. Characterization of the resulting globulin was accomplished by amino acid and elemental analyses. Variations in the ratio of N-carboxy-DL-alanine anhydride to N-carboxy-DL-4-boronophenylalanine anhydride used appeared to affect the solubility of the modified globulins. The maximum boron content of the resulting materials was approximately 36 boron atoms per molecule of protein. This technique, if applied to antitumor antibodies, may provide a means by which 10B can be localized in neoplasms. Neutron capture therapy could then be attempted.

1 Support of this research by two Unrestricted Research Grants from the Gulf Oil Foundation and by American Cancer Society Institutional Research Grant IN-58 is gratefully acknowledged.

2 The author appreciates summer support by the University of Pittsburgh Medical Alumni Association.

3 To whom correspondence should be addressed.

Received 2/28/72. Accepted 6/ 2/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.